C. Jimmy Lin
Chief Scientific Officer (CSO) at Freenome
South San Francisco, California
Overview
Work Experience
Chief Scientific Officer (CSO)
2019 - Current
Freenome is an AI genomics company on a mission to empower everyone with the tools they need to detect, treat, and ultimately prevent their diseases. By applying advanced machine learning techniques to recent breakthroughs in genomic science, Freenome is developing noninvasive blood tests to detect early-stage cancer and improve precision oncology treatments for patients everywhere. The company has raised more than $500 million from investors such as Andreessen Horowitz, Google Ventures, Polaris Partners, and Founders Fund.
Freenome is a biotechnology company with a comprehensive multiomics platform for cancer detection using a routine blood draw.
Raised $1,351,550,000.00 from BrightEdge Fund, T. Rowe Price, ArrowMark Partners, Roche, Section 32, Sands Capital Ventures, Artis Ventures (AV), Andreessen Horowitz, ARK Investment Management and Pura Vida Investments.
Venture Partner
2019
We are a new type of seed-stage fund. We believe business is now truly global. Exceptional entrepreneurs, that are building strong, category defining companies at highly advantageous valuations – can be found anywhere. We are a team highly experienced in finding such talent and helping our entrepreneurs to develop, grow, network, and scale into other markets throughout the world.
SparkLabs Global Ventures is a seed-stage investment firm.
Founder & Chief Executive Officer (CEO)
2011
We help patients with orphan diseases initiate and fund personalized research projects through a dedicated microfunding platform and highly-selective network of leading academic scientists and commercial institutions.
Chief Scientific Officer (CSO), Oncology
2015 - 2019
Natera (NASDAQ: NTRA) is a genetic testing company that develops and commercializes non-invasive methods for analyzing DNA. The mission of the company is to transform the diagnosis and management of genetic disease. In pursuit of that mission, Natera operates a CAP-accredited laboratory certified under the Clinical Laboratory Improvement Amendments (CLIA) in San Carlos, CA. Natera is also applying its unique technologies to develop non-invasive screening and diagnostic tools for earlier detection and improved treatment of cancer - finding circulating DNA (ctDNA) based on liquid biopsy methods.
Advisory Panel on Patient Engagement
2014 - 2018
PCORI is authorized by Congress to conduct research to provide information about the best-available evidence to help patients and their health care providers make better-informed health and healthcare decisions.
The Patient-Centered Outcomes Research Institute helps patients and their health care providers make more informed decisions.
Raised $191,000,000.00.
TED Fellow / Senior Fellow
2011 - 2017
TED Fellows program handpicks world-changing innovators from around the globe and brings them to the TED stage -- literally and figuratively -- to raise international awareness of their remarkable work. http://www.ted.com/pages/ted2012_fellows
TED is a technology, entertainment, and design company that offers conferences focused on ideas worth spreading.
ClinOmics: Intramural Clinical Genomics Program
2014 - 2015
Technology Transfer Center (TTC) facilitates partnerships between the NIH research laboratories and external partners.
Entrepreneur in Residence
2013 - 2014
The Mission Center L3C is a think tank for social entrepreneurs, academics, foundations and impact investors who are passionate about finding innovative, business-minded, and sustainable solutions to social problems.
The Mission Center is an online platform that offers outsourced accounting and insurance services.
Research Instructor
2011 - 2013
Visiting Scientist
2011 - 2012
National Institutes of Health is a biomedical research facility that focuses on biomedical and health-related research.
Raised $5,000,000.00 from National Institute of Allergy and Infectious Diseases.